IL5 and urinary bladder carcinoma: Also in bladder cancer, elevated IL-5 levels enhance bladder cancer cell migration and invasion through the extracellular signal-regulated kinase 1/2-mediated matrix metallopeptidase 9/nuclear factor κ/activator 1 pathway (30).